Element Biosciences Stock
HealthTechLooking to sell Element Biosciences stock or options?
Element Biosciences is a biotechnology company focused on developing innovative and affordable DNA sequencing technologies. Their platform aims to deliver high-quality genomic data with greater accuracy and flexibility, catering to a wide range of research and clinical applications. Element Biosciences seeks to democratize access to advanced sequencing capabilities, driving progress in genomics and personalized medicine.
Meritech Capital Partners, Samsung Electronics, Fusion Fund, Alexandria Venture Investments, Logos Capital, Foresite Capital, Janus Henderson Investors, JS Capital Management, Wellington Management, Venrock, RA Capital Management, T. Rowe Price Group, Morgan Stanley, Fidelity Management & Research.